CureVac Announces Financial Results for the First Quarter of 2021 and Business Updates
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced business updates and financial results for the first quarter of 2021.